Milvexian: An Oral, Bioavailable Factor XIa Inhibitor

Abstract Direct oral anticoagulants have a dose-dependent increased bleeding risk which limits use in certain populations. Studies in both animals and humans with inherited variations in factor XI levels provide a theoretical basis for a drug target capable of addressing current unmet needs. Milvexi...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Shyon Parsa, Sneha S. Jain, Olu Akinrimisi, Carolyn S. P. Lam, Kenneth W. Mahaffey
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Adis, Springer Healthcare 2024-08-01
Цуврал:	Cardiology and Therapy
Нөхцлүүд:	Milvexian Factor XI Anticoagulation Venous thromboembolism Hemostasis AXIOMATIC trials
Онлайн хандалт:	https://doi.org/10.1007/s40119-024-00379-0
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!